Cardiovascular disease, which includes coronary and
peripheral artery disease, stroke,myocardial infarct and congestive
heart failure, continues to be the leading cause of death worldwide.
Despite the clear potential for impacting human health, drug discovery
and device development in this area has been hampered by challenges in
developing predictive preclinical models for use in evaluating the
efficacy and safety of potential therapeutics. Furthermore, the
extensive range of techniques, models, and assessments relevant for drug
or device development in this space required expertise with these
models and can be time consuming. Read More
No comments:
Post a Comment